EPITOPEA
Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. Cryptigen™ TSAs are discovered by a proprietary approach deploying immunopetidomics, mass spectrometry, genomics, and bioinformatics, which allows the identification of conserved, aberrantly-expressed, tumour-specific antigens, hidden in cancer's 'junk' DNA. These hidden Cryptigen™ TSAs have been identified by research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal.
EPITOPEA
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2021-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.epitopea.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.3 M GBP
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Microsoft DNS
Investors List
Novateur Ventures
Novateur Ventures investment in Seed Round - Epitopea
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Seed Round - Epitopea
Harrington Discovery Institute at University Hospitals
Harrington Discovery Institute at University Hospitals investment in Seed Round - Epitopea
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Seed Round - Epitopea
Advent Life Sciences
Advent Life Sciences investment in Seed Round - Epitopea
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Seed Round - Epitopea
Official Site Inspections
http://www.epitopea.com
- Host name: 104.248.174.66
- IP address: 104.248.174.66
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
